A simple score for estimating the long-term risk of fracture in patients with multiple sclerosis

Marloes T Bazelier1, Tjeerd-Pieter van Staa, Bernard M J Uitdehaag

  • 1Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.

Neurology
|August 17, 2012
PubMed
Abstract

Insights

This study developed a new risk score to estimate long-term osteoporotic and hip fracture risk in patients with multiple sclerosis (MS). The score incorporates MS and other factors like falls and fatigue, improving fracture risk prediction.

Area of Science:

  • Orthopedics and Musculoskeletal Diseases
  • Neurology
  • Geriatrics

Background:

  • Osteoporotic and hip fractures pose significant health risks, particularly in aging populations.
  • Multiple sclerosis (MS) is increasingly recognized as a potential risk factor for fractures.
  • Existing fracture risk assessment tools may not adequately account for MS-specific factors.

Purpose of the Study:

  • To develop and validate a simple clinical risk score for estimating long-term osteoporotic and hip fracture risk in individuals with multiple sclerosis (MS).
  • To identify novel risk factors associated with fracture in the MS population.

Main Methods:

  • Utilized UK General Practice Research Database and National Hospital Registry data (1997-2008).
  • Identified 5,494 incident MS patients, matched 1:6 with controls.
  • Employed Cox proportional hazards models to calculate fracture risk, incorporating general and MS-specific factors, and derived integer risk scores.

Main Results:

  • The developed risk score includes MS, antidepressant use, anticonvulsant use, history of falling, and fatigue.
  • The score demonstrated moderate predictive ability for osteoporotic fractures (C-statistic=0.67) and excellent ability for hip fractures (C-statistic=0.89).
  • Estimated 5- and 10-year risks of osteoporotic and hip fracture were derived.

Conclusions:

  • This is the first clinical risk score designed for fracture risk estimation that explicitly includes multiple sclerosis (MS) as a contributing factor.
  • The score offers a novel approach to personalize fracture risk assessment in MS patients.
  • Further validation and implementation in clinical practice are warranted.